Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression (Q37470872)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 2009
edit
Language Label Description Also known as
English
Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression
scientific article published on October 2009

    Statements

    Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression (English)
    Leonie Saft
    Anna Porwit
    Eva Hellström-Lindberg
    1 October 2009
    1762-1766

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit